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Summary
The Long Island Breast Cancer Study Project is a federally mandated, population-based case-control study to
determine whether breast cancer risk among women in the counties of Nassau and Suffolk, NY, is associated
with selected environmental exposures, assessed by blood samples, self-reports, and environmental home samples.
This report describes the collaborative project’s background, rationale, methods, participation rates, and distri-
butions of known risk factors for breast cancer by case-control status, by blood donation, and by availability of
environmental home samples. Interview response rates among eligible cases and controls were 82.1% (n= 1,508)
and 62.8% (n= 1,556), respectively. Among case and control respondents who completed the interviewer-
administered questionnaire, 98.2 and 97.6% self-completed the food frequency questionnaire; 73.0 and 73.3%
donated a blood sample; and 93.0 and 83.3% donated a urine sample. Among a random sample of case and control
236 MD Gammon et al.
respondents who are long-term residents, samples of dust (83.6 and 83.0%); soil (93.5 and 89.7%); and water (94.3
and 93.9%) were collected. Established risk factors for breast cancer that were found to increase risk among Long
Island women include lower parity, late age at first birth, little or no breast feeding, and family history of breast
cancer. Factors that were found to be associated with a decreased likelihood that a respondent would donate blood
include increasing age and past smoking; factors associated with an increased probability include white or other
race, alcohol use, ever breastfed, ever use of hormone replacement therapy, ever use of oral contraceptives, and
ever had a mammogram. Long-term residents (defined as 15+ years in the interview home) with environmental
home samples did not differ from other long-term residents, although there were a number of differences in risk
factor distributions between long-term residents and other participants, as anticipated.
Introduction
The Long Island Breast Cancer Study Project
(LIBCSP) is an umbrella of projects funded by the
National Cancer Institute and National Institute of En-
vironmental Health Sciences in response to federal
legislation (Public Law 103–43, June 10, 1993), which
mandated that a study be conducted to assess envi-
ronmental and other potential risk factors contributing
to the incidence of breast cancer in the Long Island
counties of Nassau and Suffolk in New York, as well
as the two other counties in the Northeastern United
States with the highest mortality rates (Schoharie, NY,
and Tolland, CT). The multi-institutional collaborat-
ive study described here, which is the centerpiece
of the LIBCSP and is commonly referred to by that
global name, is a population-based case-control study
undertaken to determine whether the risk of breast
cancer among women residing on Long Island is asso-
ciated with polycyclic aromatic hydrocarbons (PAH)
and organochlorine compounds, such as DDT and
polychlorinated biphenyls (PCBs), assessed in blood
samples, by self-reports, or in environmental home
samples. This report includes a brief summary of the
background and rationale that catalyzed the multi-
disciplinary approach that benefitted from scientific
oversight of two external advisory groups as well as
lay community collaboration. The primary focus of
the manuscript is to provide a detailed description
of the study methods, success of the study recruit-
ment efforts, and distributions of the known breast
cancer risk factors by case-control status, by blood
sample donation, and by availability of environmental
home samples. Characteristics of persons willing to
donate blood in an epidemiologic setting will aid in
the interpretation of our study results, and facilitate
comparisons with other investigations. Results on the
primary, and other, hypotheses of the LIBCSP will
follow in separate reports.
Background
The residents of Long Island have long been con-
cerned about the potential adverse effects of envi-
ronmental contaminants, including the pesticide DDT
as described in Rachel Carson’s Silent Spring [1]. In
addition, the high incidence rates of breast cancer ob-
served in this geographic region (117.8 per 100,000 in
Nassau county and 113.6 in Suffolk county in 1992–
1996) [2], which translates into some 2,000 newly
diagnosed in situ and invasive breast cancer cases
annually, have galvanized grass-root activism on the
Island, particularly on issues relating breast cancer
with environmental contaminants (Members of the
Long Island Breast Cancer Network, 1994, personal
communication). Linking the two issues, breast cancer
risk and environmental pollution, seems to many lay
people to be a logical association. In fact, it appears
that many more members of the US general public,
in contrast to those in the scientific community, asso-
ciate environmental contaminants with breast cancer
incidence. For example, respondents of a pilot sur-
vey [3] were asked to rate their confidence that a
stated factor contributed to increasing incidence rates
of breast cancer during the 1980s. A significantly
higher proportion of the female and male lay sample of
1,019 Americans rated chemical use (56.3 and 47.3%,
respectively), pesticide residues (34.5 and 28.3%), and
electromagnetic fields (29.6 and 18.4%) as contribut-
ing to the increasing incidence as compared with the
sample of 264 scientists (25.6, 14.1, and 5.1%, re-
spectively) [3]. Thus, despite the perception shared
by many taxpayers that some environmental pollut-
ants contribute to breast cancer incidence, federal
legislation may well have been necessary to stimulate
systematic research efforts among the more skeptical
scientific community. Specific breast cancer-related
environmental concerns listed in the federal legislation
include contaminated drinking water, indoor and out-
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door air pollution, electromagnetic fields, pesticides
and other toxic chemicals, and hazardous waste.
The dramatic variation in the incidence of breast
cancer worldwide coupled with the observation that
immigrants and their offspring have incidence rates
that approach those of their adopted country, rather
than their country of origin [4], strongly support a
role for the environment in the etiology of breast can-
cer. These observations have led extensive research
on some environmental factors, including dietary in-
take [5] and active [6, 7] and passive [8, 9] ci-
garette smoking, on which results are inconclusive.
Other environmental factors which are supported by
more conclusive epidemiologic research include alco-
hol consumption [10, 11] and ionizing radiation to the
chest in moderate to high doses [12], both of which
are considered important risk factors for breast cancer
[13].
Endogenous estrogen and other hormones are pro-
posed as plausible biologic pathways by which breast
carcinogenesis is influenced by its many established
risk factors [14, 15], including menstrual character-
istics (early age at menarche and late age at meno-
pause), reproductive patterns (late age at first birth,
low parity or nulliparity, and little or no lactation),
postmenopausal body size (increased weight, height,
and body mass index (weight adjusted for height)),
and high alcohol intake. Further, a number of factors
suspected of affecting breast cancer risk (such as di-
etary patterns, physical activity, or cigarette smoking)
may act through an estrogenic or anti-estrogenic path-
way as well. Estrogen has primarily been described
as a cancer promoter, as it causes an increase in
cell turnover, which may disrupt the normal cellu-
lar process of DNA repair, thereby promoting any
existing DNA damage. In contrast, some factors
such as ionizing radiation may initiate breast carci-
nogenesis through direct induction of mutations in
DNA.
More recently, researchers have focused on the
breast carcinogenic potential of several ubiquitous
environmental agents that received little scientific at-
tention prior to the 1990s [12, 16–28]. Those that
are included in the LIBCSP for evaluation in relation
to breast cancer risk on Long Island appeared in the
early to mid 1990s to be among the most biologic-
ally plausible environmental exposures that could be
assessed with biomarkers that were feasible for use in
a population-based epidemiologic study [29]. These
include: persistent organochlorine compounds [17,
19], such as PCBs or DDT, and its metabolite DDE,
which are hormonally active agents that were used as
electrical insulators and pesticides, respectively, and
whose manufacture has been banned in the US since
the 1970s; and PAHs [17, 18], which are combus-
tion products (e.g., present in cigarette smoke, grilled
and smoked foods, and vehicle exhaust), are proven
mammary carcinogens in rodents, and may have es-
trogenic or anti-estrogenic effects [30]. The primary
exposure assessment methods used to evaluate the ef-
fect on breast cancer risk in the LIBCSP were blood
levels of organochlorines, which can be interpreted as
a life-time cumulation of exposure, and PAH-DNA
adducts, which reflect more recent exposures and
the body’s metabolic response to the exposure. En-
vironmental samples of water (for assays primarily
of chlorinated and carbamate pesticides and metals),
soil (PAH), and dust (organochlorines and PAH) were
also collected primarily for use in the validation of
geographical models that are being developed to es-
timate past exposure levels that may be specifically
associated with residence on Long Island. Another en-
vironmental concern and focus of a companion project
in the LIBCSP, is electromagnetic fields (EMF), for
which there is some biological plausibility for a role
in breast carcinogenesis. EMF may increase risk by
influencing melatonin levels, and thus estrogen levels
[16, 25].
Like other recent research efforts [31–37], the
LIBCSP will also explore whether molecular vari-
ations, in the biology of the tumor of cases or in
the estrogen or carcinogen metabolism among cases
and controls, affect breast cancer risk or modify
the relation between breast cancer risk and envi-
ronmental exposures. One strategy employed in the
LIBCSP is to determine whether breast cancer risk
is influenced by the pathways by which an individual
metabolizes estrogen, assessed through measurement
of urinary estrogen metabolites. Specifically, the
study will evaluate whether 16alpha-hydroxyestrone
and 2-hydroxyestrone are associated with the risk of
breast cancer, or whether they modify the associ-
ation between breast cancer and environmental ex-
posures. The metabolic pathways for each of these
estrogen metabolites are mutually exclusive, however,
with 16alpha-hydroxyestrone considered the more po-
tent estrogen and possibly mutagenic [34]. Further,
levels of 2-hydoroxyestrone are enhanced by exoge-
nous factors that influence endogenous estrogen
levels. Thus, the relative abundance of the two meta-
bolites may be more important than the absolute level
of either.
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Materials and methods
The LIBCSP is a population-based case-control study
of breast cancer that focuses on female residents of
Nassau and Suffolk counties in Long Island, New
York. To assess the primary exposures of interest,
organochlorine compounds and PAH, as well as po-
tential confounders, and effect modifiers, three assess-
ment methods were employed: a comprehensive in-
person questionnaire, collection of biologic samples
(blood and urine), and environmental home sampling
(dust, water, and soil). All assessments were obtained
at the time of the personal interview, and each will
be described in detail below. The study protocol was
approved by the Institutional Review Board (IRB) of
all participating institutions (the 14 collaborating sci-
entific institutions and the additional 25 participating
hospitals) and in accordance with an assurance filed




Cases were women newly diagnosed with a first
primary in situ or invasive breast cancer between Au-
gust 1, 1996, and July 31, 1997, confirmed by the
physician and the medical record, who were residents
of either Nassau and Suffolk counties in New York at
the time of their diagnosis, and who spoke English.
(Over 97% of all residents in these two counties are
English-speaking.)
The exposure assessment for the primary hypo-
theses of the LIBCSP are based on measurements
in blood. Pilot data [38, 39] indicated that blood
collection from cases after commencement of most
therapies, with perhaps the exception of chemother-
apy, would not influence the accuracy of the measures
of organochlorine levels in blood. (It is also pos-
sible that biomarkers of exposure are affected by the
disease itself, although for the two markers under
study this concern has not been clarified.) To facil-
itate collection of blood samples from cases prior to
chemotherapy, a ‘super-rapid’ identification network
was established to ascertain potentially eligible case
women with newly diagnosed breast cancer. Two to
three times per week, study personnel contacted the
pathology departments of all 28 hospitals on Long Is-
land, as well as three large tertiary care hospitals in
New York City. Seven institutions in the LI-NYC area
with the largest numbers of newly diagnosed cases
of breast cancer among LI women were contacted
daily.
Physicians of potentially eligible case women were
then contacted to confirm the subject’s diagnosis and
the date of her diagnosis, and for permission to con-
tact the subject. To promote physician cooperation,
prior to initiating subject identification, over 400 phy-
sicians on Long Island, who as general practitioners,
internists, surgeons, or oncologists had the potential
to diagnose or treat women with breast cancer, were
mailed a packet describing the study and asking them
to indicate their willingness to participate in the study
in writing. No physician refused to participate. A
total of 2,271 women were initially identified and con-
sidered as potentially eligible cases for the study. Of
these, 2,030 were determined likely to be eligible by
the physician and physician consent was obtained for
1,837 (90.5%); physician refusal for contact was gen-
erally based on a subject’s poor health status (which
was often due to age-related co-morbidity).
Controls
Control women were a sample of current residents of
Nassau and Suffolk counties who spoke English, who
did not have a personal history of breast cancer, and
who were frequency matched to the expected distribu-
tion of case women by 5-year age group. Potentially
eligible control women were identified by Waksberg’s
method of random digit dialing (RDD) [40] for those
under 65 years of age, and by Health Care Finance
Administration (HCFA) rosters for those 65 years of
age and older. HCFA selection occurred twice during
the 12-month identification period that coincided with
the 12 months of case ascertainment. RDD selection
began July 1, 1996, and continued in eight waves
over the following 12 months. The response rate to
the RDD telephone screener was 77.9%, which can
only be directly multiplied to the control response rate
for persons who are under age 65 years (and comprise
57.9% of the control group).
Subject recruitment
Potentially eligible controls and cases with physician
consent were first contacted by the study team by
overnight letter. Initial recruitment efforts that used
overnight service generated undue concern among
some potential control women who were 65 years of
age and older; subsequently older potential controls
were contacted by a regularly mailed letter. The re-
cruitment letter explained the study purpose, the vari-
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ous components of the study interview (the in-person
questionnaire, the biologic specimen collection, and
the home sampling component), that the study was
completely voluntary, and that they could choose to
participate in any or all of the components for which
they were selected. The packet sent to potential par-
ticipants also included a brightly colored flyer that
answered commonly asked questions about the study.
In addition, the packet included a form letter signed
by the Long Island Breast Cancer Network members,
a community-based organization, explaining that this
unique study was a direct result of the community’s
activism and urging women to consider participation.
To further enhance study recognition and credibil-
ity, community activists placed IRB-approved public
service announcements in local newspapers and on
television and radio, and circulated study newsletters
and brochures in multiple settings such as libraries,
physicians’ offices, and health fairs. Study recruit-
ers contacted the study subjects to answer questions
and arrange for a study interview. For most wo-
men, recruiters contacted potential respondents by
telephone; for some control women who were difficult
to locate by telephone, potential respondents were ap-
proached in person. Written signed informed consent
was obtained from participants prior to conducting any
component of the interview.
Subject participation
The main questionnaire was completed by 1,508
(82.1%) of eligible case women (n= 235 with in
situ and 1,273 with invasive breast cancer) and 1,556
(62.7%) of eligible control women (Table 1). The rea-
sons for non-response to the interview among cases
and controls included subject refusal (n= 218 (12.4%)
and 573 (21.6%), respectively); too ill, cognitively im-
paired, or deceased (76 (4.1%) and 193 (7.8%)), and
unlocatable, moved out of area, or other (26 (1.4%)
and 195 (7.9%)). Study subjects ranged in age from
20 to 98 years and, as shown in Table 1, response to
the interview varied with the age of the respondents,
with 88.9% of cases and 76.1% of controls under age
65 years participating versus 71.6 and 43.3%, respec-
tively, among those 65 and older. The average length
of time between the referent date (date of diagnosis
for cases and date of identification for controls) and
interview date was 96 days for cases and 167 days for
controls.
For case women, final study eligibility was based
upon thorough review of the medical record (for an
accurate date of diagnosis of a first primary), which
could only be obtained with a signed medical record
consent form. For controls, final eligibility (no history
of prior breast cancer and a resident of Long Island at
the reference date) could only be obtained after direct
contact with the subject. Therefore, the interview re-
sponse rates presented may be underestimates, as they
include in the denominator 25 potentially eligible case
women and 193 potentially eligible control women for
whom study eligibility could not be determined be-
cause they were never located or had moved out of
the area. If unlocatable women are omitted from the
denominator, as suggested by Slattery (41) and others
(42), then the overall interview response rates (also
known as cooperation rates) are 83.2 and 68.0% for
cases and controls, respectively, as shown in Table 1.
The true response rates probably lie between the two
sets of estimates.
Questionnaires
Prior to implementation in the field, the main question-
naire was pilot tested among residents of Long Island
and developed with contributions from scientific and
community collaborators. During field activities, the
instrument, which averaged 101 min in duration, was
administered by a trained interviewer in the respond-
ent’s home. Respondents were asked about their preg-
nancy history; occupational history; residential history
in Nassau and Suffolk counties; their use of pesticides
in and around their home or on a farm; electrical appli-
ance use; lifetime history of consumption of smoked
or grilled foods; medical history; family history of
cancer; body size changes by decade of life; lifetime
participation in recreational physical activities; act-
ive and passive cigarette smoking; use of alcohol by
decade of life; menstrual history; use of exogenous
hormones; and demographic characteristics.
After administration of the main questionnaire,
study respondents were invited to self-administer a
modification of the Block food frequency question-
naire, which has been previously validated (43–45).
This instrument was completed by 98.2% (n= 1,481)
of case and 97.6% (n= 1,518) of control participants;
all participants self-completed the instrument in an
average of 36 min immediately after the main ques-
tionnaire had been completed. Response for this
component did not appear to vary with age of the
respondent (Table 2).
As a quality control measure, a random 20% of
all respondents were recontacted by telephone to in-
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Table 1. Response, cooperation, and contact rates to the main questionnaire (Qx) by age at reference among case and control subjects,
Long Island Breast Cancer Study Project, 1996–1997
Study subject status All Age at reference (in years)
<45 45–54 55–64 65–74 75+
Cases
Sampled 2271 307 526 504 567 367
Ineligible 241 37 48 44 68 44
MD refusal 193 20 38 38 42 55
Eligible (A) 1837 250 440 422 457 268
Unlocatable or out of area (B) 25 4 2 8 5 6
Subject refusal 217 23 33 33 67 61
Too ill 31 1 1 3 8 18
Cognitively impaired 29 1 2 2 7 17
Deceased 16 0 2 4 3 7
Other 1 0 1 0 0 0
Partially completed main qx 10 0 2 1 3 4
Completed main qx (C) 1508 221 397 371 364 155
Contact rate= (A−B)/A=D 98.6% 98.4% 99.5% 98.1% 98.9% 97.8%
Cooperation rate=C/(A−B)=E 83.2% 89.8% 90.6% 89.6% 80.5% 59.2%
Response rate=D∗E=C/A 82.1% 88.4% 90.2% 87.9% 79.6% 57.8%
Controls
Sampled 2714 411 575 587 661 480
Ineligible 233 19 35 50 72 57
Eligible (A) 2481 392 540 537 589 423
Unlocatable or out of area (B) 193 17 21 24 69 62
Subject refusal 530 70 98 89 161 112
Too ill 101 3 4 10 34 50
Cognitively impaired 67 2 0 1 11 53
Deceased 25 0 0 4 5 16
Other 2 1 1 0 0 0
Partially completed main qx 7 1 3 2 1 0
Completed main qx (C) 1556 298 413 407 308 130
Contact rate= (A−B)/A=D 92.2% 95.7% 96.1% 95.5% 88.3% 85.3%
Cooperation rate=C/(A−B)=E 68.0% 79.5% 79.6% 79.3% 59.2% 36.0%
Response rate=D∗E=C/A 62.7% 76.0% 76.5% 75.8% 52.3% 30.7%
sure that the interview actually occurred, verify the
length of the interview, and to briefly re-interview
the subjects. Completed questionnaires were shipped
to Westat, Inc., Bethesda, MD, for data verifica-
tion, coding, data entry, and initial range and logic
checks.
Biologic sample collection
Study interviewers, who were certified phlebotom-
ists or nurses, obtained biologic samples; 73.1%
(n= 1,102) and 73.3% (n= 1,141) of case and control
respondents who had completed the main interview,
respectively, donated a nonfasting 40 ml blood sample,
and 93.0% (n= 1,403) and 83.3% (n= 1,296) donated
a 25 ml spot urine sample at the time of the interview.
Donation of biologic samples varied with age, with
a lower proportion of older control women donating
blood and urine (Table 2). The proportion of case
respondents with biologic specimens collected prior
to chemotherapy was 77.2% (851/1102) for blood
and 75.1% (1053/1403) for urine. To further invest-
igate whether samples collected after chemotherapy
differed from samples collected prior to chemother-
apy [38], 190 case women for whom prechemotherapy
samples had been collected were selected for recontact
at a later date to obtain samples after commencement
of chemotherapy. Of these, 148 (77.9%) cases donated
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Table 2. Response rates by study interview component and age at reference among respondents, Long Island Breast Cancer Study Project,
1996–1997
Study interview component All Age at reference
<45 yrs 45–54 yrs 55–64 yrs 65–74 yrs 75+ yrs
Cases
Questionnaires Main 1508 221 397 371 364 155
% 100% 100% 100% 100% 100% 100%
FFQ 1481 213 389 371 357 151
% 98.2% 96.4% 98.0% 100.0% 98.1% 97.4%
Biologic Specimens Blood 1102 163 292 268 268 111
% 73.1% 73.8% 73.6% 72.2% 73.6% 71.6%
Urine 1403 209 370 343 337 144
% 93.0% 94.6% 93.2% 92.5% 92.6% 92.9%
Environmental Dust 320 15 86 99 97 23
Home samples % 83.6% 83.3% 85.1% 90.0% 81.5% 65.7%
Soil 360 18 98 104 111 29
% 93.5% 100.0% 95.1% 94.5% 93.3% 82.9%
Water 363 17 98 106 112 30
% 94.3% 94.4% 96.1% 96.4% 93.3% 85.7%
Medical records Signed 1473 213 383 365 357 155
% 97.7% 96.4% 96.5% 98.4% 98.1% 100.0%
Retrieved 1402 206 361 344 343 147
% 95.2% 96.7% 94.3% 94.2% 96.1% 94.8%
Controls
Questionnaires Main 1556 298 413 407 308 130
% 100% 100% 100% 100% 100% 100%
FFQ 1518 292 405 401 300 120
% 97.6% 98.0% 98.1% 98.5% 97.4% 92.3%
Biologic specimens Blood 1141 229 318 312 206 76
% 73.3% 76.8% 77.0% 76.7% 66.9% 58.5%
Urine 1296 254 370 354 231 87
% 83.3% 85.2% 89.6% 87.0% 75.0% 66.9%
Environmental Dust 356 15 88 133 91 29
Home samples % 83.0% 65.2% 77.9% 87.5% 85.8% 82.9%
Soil 360 21 99 142 92 31
% 93.5% 91.3% 87.6% 93.4% 86.8% 88.6%
Water 363 20 106 145 100 32
% 94.3% 87.0% 93.8% 95.4% 94.3% 91.4%
a postchemotherapy blood sample and 155 (81.6%)
donated a postchemotherapy urine sample.
At the time of the blood and urine collection,
donors were asked to self-complete a specimen check-
list which inquired about the date of the subject’s
last menstrual period (if she was still menstruating);
selected foods consumed and medications used, and
cigarettes smoked over the past several days; intake
of PAH-containing foods over the past 4 weeks, and
any breast surgeries or treatment undergone in the past
6 months. With the blood (which was collected in
EDTA-treated, lavender-top tubes) at room temper-
ature and the urine (with vitamin C added to about
one-half the volume of each donation) on ice, the
biologic samples were shipped overnight to a single
laboratory at Columbia University. Biologic specimen
242 MD Gammon et al.
collection was avoided on days and times when
overnight services were not available. Thus, pro-
cessing and aliquoting of the biologic samples oc-
curred for most subjects within 24 h of collection.
Aliquots of plasma, red blood cells, mononuclear
cells, and granulocytes from 40 ml of blood and ali-
quots with and without vitamin C from 25 ml of urine
are stored at −80 degrees centigrade with bar-code la-
bels, which are preprinted with the subjects’ randomly
selected study identification number. All lab personnel
are blinded to the case-control status of the specimens.
Environmental home sampling
An invitation to participate in the environmental home
sampling component was extended to all long-term
residents who self-identified themselves as African-
American or black, and a random sample of long-term
residents who self-identified as white. Long-term res-
idence was defined as living in the current home for
15 years or longer. About 58% of all participants
were potentially eligible for this component of the
study; of these, a random sample of about 36% were
targeted for sampling. Environmental home samples
were obtained directly after the completion of the main
questionnaire and the food frequency questionnaire,
and the donation of blood and urine. The samples were
collected by the interviewer and included: carpet dust
(83.6% (320/383) and 83.0% (356/429) of selected
long-term case and control residents, respectively); tap
water (94.3% (363/385) and 93.9% (403/429)), and
soil outside the home (93.5% (360/385) and 89.7%
(356/429)). The proportion of the selected case and
control respondents who refused to permit collection
of the home samples was modest (3.4 and 5.9%, re-
spectively, for dust; 3.9 and 4.0% for water; and 3.5
and 3.5% for soil). Response to the environmental
home sampling component did not appear to vary
substantially with age among cases and controls, al-
though soil samples were obtained for a slightly lower
proportion of case women 75 years of age and older
(Table 2).
Using high-volume small surface samplers
((HVS3), CS3, Inc., Bend, OR), dust was collected
from the carpet located in the room of the home in
which the respondent reported spending the most time.
The carpet area to be vacuumed was measured and re-
corded along with the age and other characteristics of
the rug. After vacuuming, the Teflon collection bottles
with the collected dust were shipped by overnight mail
to Southwest Research Institute, San Antonio, TX;
sieved (<150 micron) aliquots were stored at −12 de-
grees centigrade. The 79 homes (44 cases, 35 controls)
from which sample collection was not feasible (9.7%)
lacked a carpet, or sufficient amount of dust required
for the assays (0.1 gm) could not be obtained.
Water samples were collected from the kitchen
tap in both glass and plastic bottles using a standard
protocol. Along with duplicates and quality control
samples, all water samples were delivered on ice by
the interviewer to one of two centralized locations on
Long Island, where they were kept refrigerated. Per-
sonnel from the Suffolk County Department of Health,
Hauppauge, NY, retrieved the refrigerated samples
several times per week. Water assays were completed
at the Suffolk County Department of Health within
seven 7 of sample collection.
Soil was collected according to a protocol estab-
lished in collaboration with members of the study’s
external advisory committee based on unpublished
results from a pilot study conducted by members of
the study team. With a stainless steel soil sampler
(Oakfield 12′′ Tube Kit (Model G), Forrestry Suppli-
ers, Inc., Jackson, MS), samples were obtained from
four locations in each of the participants’ yards: center
of yard closest to the road; center of yard farthest from
the road; foundation by most frequently used entry;
and foundation of next most frequently used entry.
Quality control samples and soil samples were placed
in plastic bags, individually labeled with the location
from which the sample was obtained, and shipped by
overnight mail to the American Health Foundation,
Valhalla, NY, and stored at −20 degrees centigrade.
Failure to collect soil was usually due to lack of a yard
rather than weather conditions, because the 1996–
1997 winter season on Long Island was unusually
mild.
All environmental home samples were labeled
by the interviewer with a bar code label preprinted
with the subjects’ randomly selected study identifi-
cation number. All laboratory personnel are blinded
to the case-control status of the environmental home
samples.
Other field activities
Cases were asked to sign a medical record release form
that would permit determination of final study eligi-
bility as well as the clinical characteristics of her breast
cancer diagnosis (e.g., stage of disease, hormone re-
ceptor status). Signed medical record release forms
were obtained for 1,473 (97.7%) case respondents, and
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records were successfully located and abstracted for
1,402 (95.2%). Because a goal of the study was to
collect blood samples prior to chemotherapy [38, 39],
most case women were interviewed prior to the com-
pletion of their course of treatment; thus, complete
treatment information is not available on the majority
of case subjects.
After completing the interview, subjects were in-
formed that they might be contacted in the near future
by researchers at the State University of New York at
Stony Brook about the opportunity to participate in a
companion study of electromagnetic fields and breast
cancer risk. An informational brochure was left with
the study subject, along with a telephone number to
call with any questions.
Professional and community collaboration
Broad scientific expertise in epidemiology, clinical
care, toxicology, environmental assessment, carcino-
genesis, and other disciplines was drawn from local,
as well as nationally-based, institutions, to adequately
address the study aims of this federally mandated pro-
ject. In addition, this study has had the benefit of
close working relations with community activists in
developing the study hypotheses and design, and dur-
ing pilot-testing and field activities. Lay persons were
often able to provide a fresh outlook to our plans
and procedures, but at no time were they permitted
access to confidential subject information. Scientific
oversight was provided by two external advisory com-
mittees that included both scientists and lay persons.
The committees formally convened in-person annu-
ally, and informally by telephone more frequently.
Statistical analyses
For the results reported here, chi-square statistics
were calculated [46]. Unconditional logistic regres-
sion [47] was used to estimate the odds ratios for
donating a blood sample to the study in relation to
known and suspected risk factors for breast cancer
including age (at reference = date of diagnosis for
cases and identification for controls), case-control
status, race (self-identified as white/African-American
or black/or other), ethnicity (Hispanic or Latino/not
Hispanic or Latino), education (less than high school/
high school graduate/some college/college gradu-
ate/post college), marital status (ever/never), re-
ligion (in which the respondent was raised), in-
come (self-reported), age at menarche (<12 years/12
years/13 years/14+ years), parity (nulliparous/parous
and number of children), age at first birth (<22
years/22–24 years/25–27 years/28+ years), lactation
(<2 months/2–5 months/6–13 months/14+ months),
menopausal status (pre-/postmenopausal), cigarette
smoking (never/current (within 12 months of reference
date)/quit more than 12 months before reference date),
alcohol use (ever (at least once a month for 6 months
or more)/never), body mass index (BMI)) weight in
kilograms/height in meters squared) at age 20 years
and at reference, family history of breast cancer (in
mother or sister), oral contraceptive use (ever/never),
and hormone replacement (ever/never). To determine
the best predictors of donating blood, a best-fitting
multiple logistic regression model was identified using
backwards selection, where covariates were system-
atically removed from the model by comparing the
log likelihood ratios derived from a model with and
without the covariate, using a nominal significance
criteria of 10%.
Menopausal status was defined using information
provided by the subject on her date of last menstrual
period, prior surgical information on hysterectomy
or oophorectomies, her cigarette smoking status, and
use of hormone replacement. A subject was defined
as postmenopausal if her last menstrual period was
more than 6 months before the reference date or if
she had both ovaries removed prior to reference date.
If a subject was taking hormone replacement ther-
apy or had a hysterectomy without removal of both
ovaries, her menopausal status was initially classi-
fied as unknown (11.81% of subjects). To reduce the
number of subjects with unknown menopausal status,
we utilized information about the subject’s reference
age. That is, any smoker with unknown menopausal
status was categorized as postmenopausal if her age
at reference was ≥54.8 years (90% percentile for nat-
ural menopause among smoking controls), and any
nonsmoker with unknown menopausal status was cat-
egorized as postmenopausal if her age at reference was
≥55.4 years (90% percentile for natural menopause
among nonsmoking controls). Subjects whose final
classification of menopausal status was missing was
3.04%.
Results
Many established risk factors for breast cancer that
have been identified in previous studies [13] were con-
firmed to affect risk among women of all ages on
Long Island (Table 3). These included parity (age-
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Table 3. Age-adjusted odds ratios (OR) and 95% confidence intervals (CI) for breast cancer in relation to known and suspected
risk factors, Long Island Breast Cancer Study Project, 1996–1997
Factor Cases Controls Age-adjusted
(n= 1,508) (n= 1,556) OR (95% CI)
No. % No. %
Demographic factors
Age at reference <35 years 39 2.6 45 2.9
35–44 years 181 12.0 245 15.7
45–54 years 397 26.3 423 27.2
55–64 years 372 24.7 403 25.9
65–74 years 365 24.2 310 19.9
75–84 years 134 8.9 112 7.2
85+ years 20 1.3 18 1.2
Missing 0 0
Race White 1411 93.8 1429 91.8 1.00
Black 69 4.6 85 5.5 0.85 (0.61, 1.18)
Other 25 1.7 42 2.7 0.64 (0.39, 1.05)
Missing 3 0
Latina or hispanic No 1448 96.2 1487 96.0 1.00
Ethnicity Yes 57 3.8 62 4.0 0.99 (0.69, 1.43)
Missing 3 7
Education <High school 183 12.2 150 9.7 1.00
High school graduate 538 35.8 526 33.9 0.89 (0.70, 1.15)
Some college 360 24.0 415 26.7 0.78 (0.60, 1.03)
College graduate 191 12.7 236 15.2 0.75 (0.56, 1.02)
Post college 230 15.3 225 14.5 0.94 (0.69, 1.26)
Missing 6 4
Marital status Ever married 1443 95.8 1486 95.5 1.00
Never married 64 4.2 70 4.5 1.00 (0.70, 1.42)
Missing 1 0
Religion Catholic 859 57.1 916 59.0 1.00
Protestant 360 23.9 373 24.0 1.02 (0.86, 1.21)
Jewish 259 17.2 239 15.4 1.16 (0.95, 1.42)
None 14 0.9 12 0.8 1.28 (0.59, 2.80)
Other 13 0.9 13 0.8 1.13 (0.52, 2.45)
Missing 3 3
Income <$15,000 115 8.9 84 6.4 1.00
$15,000–$19,999 70 5.4 83 6.3 0.60 (0.39, 0.93)
$20,000–$24,999 78 6.0 98 7.5 0.59 (0.39, 0.90)
$25,000–$34,999 176 13.6 139 10.6 1.05 (0.72, 1.52)
$35,000–$49,999 192 14.8 203 15.5 0.82 (0.57, 1.17)
$50,000–$69,999 214 16.5 245 18.7 0.81 (0.56, 1.16)
$70,000–$89,999 169 21.7 177 13.5 0.90 (0.62, 1.32)
$90,000+ 281 13.1 281 21.5 0.96 (0.67, 1.38)
Missing 213 246
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Table 3. (continued)
Factor Cases Controls Age-adjusted
(n= 1,508) (n= 1,556) OR (95% CI)
No. % No. %
Reproductive factors
Age at menarche <12 years 391 26.1 437 28.2 1.00
12 years 418 28.0 400 25.9 1.16 (0.95, 1.41)
13 years 379 25.4 359 23.2 1.17 (0.96, 1.43)
14+ years 307 20.5 351 22.7 0.94 (0.7, 1.16)
Missing 13 9
Parity status Nulliparous 198 13.1 171 11.0 1.00
Parous 1310 86.9 1385 89.0 0.78 (0.63, 0.98)
1 child 166 12.7 148 10.7 0.97 (0.72, 1.32)
2 children 508 38.8 518 37.4 0.83 (0.65, 1.05)
3 children 358 27.3 379 27.4 0.78 (0.60, 1.00)
4+ children 278 21.2 340 24.5 0.63 (0.48, 0.82)
Missing 0 0
Age at first birth <22 years 305 23.3 358 25.9 1.00
(among parous) 22–24 years 375 28.6 417 30.1 1.03 (0.84, 1.27)
25–27 years 272 20.8 297 21.4 1.06 (0.85, 1.33)
28+ years 357 27.3 313 22.6 1.36 (1.10, 1.69)
Missing 1 0
Lactation Never lactated 841 64.2 840 60.7 1.00
(among parous) <2 months 118 9.0 124 9.0 0.95 (0.72, 1.24)
2–5 months 103 7.9 128 9.2 0.82 (0.62, 1.09)
6–13 months 146 11.1 140 10.1 1.06 (0.82, 1.36)
14+ months 102 7.8 153 11.0 0.70 (0.54, 0.92)
Missing 0 0
Lifestyle factors
Body Mass Index <22.3 341 22.9 382 25.0 1.00
at reference 22.3–25.1 367 24.6 391 25.6 1.02 (0.84, 1.26)
25.2–29.2 391 26.2 376 24.6 1.10 (0.90, 1.36)
>29.2 392 26.3 379 24.8 1.10 (0.90, 1.35)
Missing 17 28
Body Mass Index <19.0 371 25.1 373 24.4 1.00
at age 20 19.0–20.2 346 23.4 364 23.8 0.95 (0.77, 1.16)
20.3-22.2 442 29.8 399 26.0 1.10 (0.91, 1.34)
>22.2 321 21.7 396 25.8 0.82 (0.67, 1.00)
Missing 28 24
Alcohol use Never 588 39.0 593 38.1 1.00
Ever 920 61.0 963 61.9 1.00 (0.86, 1.15)
Missing 0 0
Cigarette Never smoked 675 44.8 698 45.0 1.00
smoking Former smoker 543 36.0 564 36.3 1.00 (0.85, 1.17)
Current smoker 290 19.2 291 18.7 1.09 (0.90, 1.32)
Missing 0 3
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Table 3. (continued)
Factor Cases Controls Age-adjusted
(n= 1,508) (n= 1,556) OR (95% CI)
No. % No. %
Medical factors
Family history No first degree 1166 79.8 1321 87.0 1.00
of breast cancer First degree 295 19.2 197 13.0 1.66 (1.36, 2.02)
Missing 47 38
Use of oral Never 848 56.3 840 54.0 1.00
contraceptives Ever 657 43.7 715 46.0 1.06 (0.90, 1.24)
Missing 3 1
Use of hormone Never 1096 72.9 1159 74.5 1.00
replacement Ever 408 27.1 396 25.5 1.06 (0.90, 1.25)
Missing 4 1
adjusted OR= 0.63 for 4+ children v.s. none, 95%
CI= 0.48, 0.82), breastfeeding (OR= 0.70 for 14
months v.s. none, 95% CI= 0.53, 0.89), age at first
birth (OR= 1.36 for 28+years v.s. <22 years, 95%
CI= 1.10, 1.69), and family history of breast cancer in
mother or sister (OR= 1.66 v.s. none, 95% CI= 1.36,
2.02). In this initial evaluation, factors found not to
influence risk in this study included education, age
at menarche, weight adjusted for height, and alcohol
use.
Using blood donation as the outcome variable,
multivariate models were constructed to identify
factors associated with the likelihood of donating
blood (expressed as the odds ratio for blood dona-
tion) among interviewed subjects with adjustments
made for the potential confounders including case-
control status, as described in the methods. Factors
found to be associated with a decreased probability of
blood donation among case and control respondents
were past smoking (multivariate-adjusted OR= 0.75
v.s. never, 95% CI= 0.61, 0.92) and increasing age
(OR= 0.99 per year, 955 CI= 0.98, 1.00) (Table 4).
Factors that were associated with an increased prob-
ability of blood donation (Table 4) included white
or other race (OR= 1.65 and 1.74, respectively, v.s.
black, 95% CI= 1.09, 2.46 and 085, 3.55), ever
use of alcohol (OR= 1.28, 95% CI= 1.06, 1.55),
ever use of hormone replacement (OR= 1.63 v.s.
never, 95% CI= 1.30, 2.03), breast fed for six or
more months (OR= 1.47 v.s. never, 95% CI= 1.14,
1.90), and ever had a mammogram (OR= 1.51 v.s.
never, 95% CI= 1.14, 2.00). Case-control status was
not a predictor of blood donation among interview
respondents.
As anticipated, respondents who reported liv-
ing in their current home for 15 years or longer
differed on a number of breast cancer risk factors
from those who were not long-term residents
(Table 5). Long-term residents as compared with
other LIBCSP participants were significantly more
likely to be older (p= 0.001), white (p= 0.001), less
educated (p= 0.001), postmenopausal (p= 0.001),
older at menopause (p= 0.007), and never or
past smokers (p= 0.001); and to have lower in-
comes (p= 0.001), more children (p= 0.001), never
breastfed (p= 0.001), a higher body mass index
(p= 0.001), ever drank alcohol (p= 0.001), never
used oral contraceptives (p= 0.001), and ever used
hormone replacement (p= 0.001); and to have ever
had a mammogram (p= 0.001).
The random sample of 589 respondents for whom
a complete set of environmental home samples (dust,
water, and soil) were obtained did not differ from all
long-term residents on the overwhelming majority of
breast cancer risk factors assessed (Table 6). The ex-
ception was body size; those with dust, water, and
soil samples available reported a lower BMI at age
20 (p= 0.03) than other long-term residents. African-
Americans comprise a larger proportion of those for
whom environmental home samples were collected, as
compared with those for whom samples were not ob-
tained, because all black respondents were invited to
participate in this component, whereas only a random
sample of white respondents were invited.
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Table 4. Multivariate-adjusted∗ odds ratios (OR)∗∗ and 95% confidence intervals (CI) for the phlebotomy component
in relation to known and suspected risk factors for breast cancer among case and control respondents, Long Island
Breast Cancer Study Project, 1996–1997
Factor Multivariate-adjusted OR 95% CI
Age at reference (Per year) 0.99 0.98, 1.00
Race African-American 1.00
White 1.65 1.10, 2.48
Other 1.74 0.85, 3.55
Cigarette smoking Never smoked 1.00
Former smoker 0.75 0.61, 0.92
Current smoker 0.89 0.69, 1.15
Alcohol use Never 1.00
Ever 1.28 1.06, 1.55
Use of oral Never 1.00
contraceptives Ever 1.21 0.99, 1.49
Use of hormone Never 1.00
replacement Ever 1.63 1.30, 2.03
Lactation None 1.00
<6 months 1.02 0.79, 1.32
6+ months 1.47 1.14, 1.90
Mammography Never 1.00
Ever 1.51 1.14, 2.00
∗Odds ratios adjusted for all other factors listed in the table.
∗∗Odds ratios greater than 1.0 indicate that the factor is associated with a greater probability of blood donation; less
than 1.0 indicates the factor is associated with a lower probability of blood donation.
Discussion
The Long Island Breast Cancer Study Project is a large
epidemiologic study designed to evaluate whether
several environmental factors are associated with el-
evated risk of breast cancer. The study is complex
and ambitious on a number of levels including ef-
forts to involve community members in the design
and conduct of various components of the study; a
multi-disciplinary, multi-institutional scientific collab-
oration; oversight from two external advisory com-
mittees composed of both scientific and community
leaders; implementation of a super-rapid reporting
method in a geographic location that has had limited
experience with population-based studies of cancer;
inclusion of women of all ages; utilization of multiple
enhancements designed to boost study participation
(including contacting physicians prior to the inception
of field operations, first contacting most subjects by
overnight service, including in the recruitment pack-
age a form letter from local breast cancer activists that
explained the unique origins of the study, employment
of skilled subject recruiters, and an in-person re-
cruitment strategy, where possible); multiple methods
employed to assess environmental exposures; and es-
tablishment of a biologic specimen bank, that includes
blood (including DNA) and urine, and an environ-
mental sample bank of dust and soil. Nevertheless, a
number of important concerns must be considered in
interpreting any results emanating from this study or
related projects.
Subject participation
Despite our extensive identification and recruitment
efforts, response rates were lower among controls
than in cases, which was driven by poor participa-
tion among elderly control women. Lower response
among elderly women have been previously repor-
ted in case-control studies of breast cancer [42] and
other diseases, such as hip fractures [48]. This pro-
ject is unique among epidemiologic studies of breast
248 MD Gammon et al.
Table 5. Percent distribution of known and suspected risk factors for breast cancer among case and control respondents by
residency status, Long Island Breast Cancer Study Project, 1996–1997
Factor Long-term Non-long-term Chi-square
residents (%) residents (%) P -value
(n= 1,769) (n= 1,295)
Demographic factors
Age at reference <35 years 0.6 5.6 0.0001
35–44 years 4.1 27.2
45–54 years 26.2 27.6
55–64 years 30.9 17.6
65–74 years 27.4 14.7
75–84 years 9.6 5.9
85+ years 1.2 1.4
Race White 94.7 90.2 0.0001
Black/African-American 3.6 7.0
Other 1.8 2.8
Education Less than high school 10.8 11.0 0.0001
High school graduate 38.4 30.0
Some college 25.1 25.8
College graduate 11.7 17.1
Post college 14.0 16.1














Age at menarche <12 years 28.1 27.2 0.31
12 years 26.7 26.7
13 years 23.0 25.6
14+ years 22.2 20.5
Parity status Nulliparous 9.9 15.0 0.001
Parous 90.1 85.0
1 child 9.4 15.0 0.0001
2 children 37.3 39.2
3 children 29.0 25.0
4+ children 24.4 20.8
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Table 5. (continued)
Factor Long-term Non-long-term Chi-square
residents (%) residents (%) P -value
(n= 1,769) (n= 1,295)
Age at first birth <22 years 23.0 27.1 0.0001
(among parous) 22–24 years 22.8 17.3
25–27 years 26.5 19.1
28+ years 27.7 36.6
Lactation Never lactated 67.8 54.6 0.0001
(among parous) <2 months 9.3 8.5
2–5 months 6.5 11.6
6–13 months 9.8 11.8
14+ months 6.7 13.5
Menopausal Premenopausal 20.2 50.1 0.0001
status Postmenopausal 79.8 49.9
Lifestyle factors
Body Mass Index <22.3 20.8 28.2 0.0001
at reference 22.3–25.1 25.1 25.1
25.2–29.2 26.5 23.9
>29.2 27.6 22.8
Body Mass Index <19.0 23.6 26.3 0.12
at age 20 19.0–20.2 24.5 22.2
20.3–22.2 28.8 26.7
>22.2 23.1 24.8
Alcohol use Never 41.9 34.0 0.0001
Ever 58.1 66.0
Cigarette Never smoked 45.4 44.1 0.0001
smoking Former smoker 38.6 32.9
Current smoker 16.0 23.0
Medical factors
Family History No first degree 83.8 83.0 0.56
of Breast Cancer First degree 16.2 17.0
Use of oral Never 60.7 47.6 0.0001
contraceptives Ever 39.3 52.4
Use of hormone Never 70.6 78.0 0.0001
replacement Ever 29.4 22.0
Mammography None 11.5 17.5 0.0001
Within last 5 years 1+ 88.5 82.5
cancer in that there was no upper or lower age limit
for subject eligibility. Comorbidity among the eld-
erly and the protective efforts of the subjects’ families
prevented full study participation among these older
women. Thus, if the older respondents somehow dif-
fer systematically from older non-respondents, results
based on this segment of LIBCSP data should be
interpreted cautiously and may not be generalizable
to all older women. Nevertheless, the LIBCSP will
be among the few studies that can provide extens-
ive data on the epidemiology of breast cancer among
women 65 years of age and over, who comprise
over a third of all those newly diagnosed with the
disease.
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Table 6. Percent distribution of known and suspected risk factors for breast cancer among case and control respondents
who are long-term residents by completion of environmental home sampling component, Long Island Breast Cancer
Study Project, 1996–1997
Factor Complete set of No complete set Chi-square
water/dust/soil of water/dust/soil P -value
(%) (n= 589) (%) (n= 1,180)
Demographic factors
Age at Reference <35 years 0.5 0.6 0.23
35–44 years 2.6 3.2
45–54 years 22.7 24.1
55–64 years 34.5 30.8
65–74 years 30.7 26.9
75–84 years 8.7 12.4
85+ years 0.4 2.0
Race White 92.0 96.0 0.0001
Black/African-American 6.6 2.0
Other 1.4 2.0
Education Less than high school 8.2 12.1 0.14
High school graduate 40.7 37.2
Some college 25.0 25.1
College graduate 11.6 11.7
Post college 14.5 13.8














Age at menarche <12 years 27.9 27.4 0.86
12 years 25.7 27.5
13 years 23.3 23.1
14+ years 23.1 22.0
Parity status Nulliparous 9.2 10.3 0.47
Parous 90.8 89.7
1 child 9.2 9.2 0.31
2 children 35.7 38.0
3 children 28.4 29.3
4+ children 26.1 23.5
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Table 6. (continued)
Factor Complete set of No complete set Chi-square
water/dust/soil of water/dust/soil P -value
(%) (n= 589) (%) (n= 1,180)
Age at first birth <22 years 24.7 22.1 0.64
(among parous) 22–24 years 23.0 22.7
25–27 years 26.0 26.8
28+ years 26.3 28.4
Lactation Never lactated 69.4 67.0 0.41
(among parous) <2 months 8.0 10.0
2–5 months 7.1 6.1
6–13 months 9.4 10.0
14+ months 6.2 6.9
Menopausal Premenopausal 19.8 20.4 0.74
status Postmenopausal 80.2 79.6
Lifestyle factors
Body Mass Index <22.3 20.9 20.8 0.25
at reference 22.3–25.1 26.7 24.3
25.2–29.2 23.6 28.0
>29.2 28.8 26.9
Body Mass Index <19.0 26.4 22.1 0.028
at Age 20 19.0–20.2 25.5 24.0
20.3–22.2 28.9 28.8
>22.2 19.2 25.1
Alcohol use Never 44.6 40.7 0.14
Ever 55.4 59.3
Cigarette Never smoked 45.2 45.5 0.34
smoking Former smoker 40.4 37.7
Current smoker 14.4 16.8
Medical factors
Family history No first degree 84.4 84.0 0.74
of breast cancer First degree 16.6 16.0
Use of oral Never 60.5 60.8 0.87
contraceptives Ever 39.5 39.2
Use of hormone Never 69.1 71.4 0.32
replacement Ever 30.9 28.6
Mammography None 9.0 12.8 0.064
Within last 5 years 1+ 91.0 87.2
Another contribution to the lower participation re-
sponse rates observed among controls is the lower
screener rate obtained during RDD, which affects res-
ults based on women under age 65 years. RDD has
been an effective and common technique to identify a
pool of potentially eligible population-based controls
since the technique was introduced by Waksberg [40]
in the late 1970s. Olson and colleagues [49] observed
few differences between a group of hypothetical con-
trols identified through RDD versus those identified
through a household census of the same community,
although the RDD screener rate in the Olson study
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was higher than the rate reported here. With the in-
creasing use of telephone message machines and caller
ID, particularly in high-income areas such as Long
Island where residents are subjected to extensive tele-
phone marketing, the RDD technique may be less
effective.
It is reassuring to note that in general we observed
in the LIBCSP many of the established risk factors
for breast cancer noted in other epidemiologic stud-
ies [13], including family history of breast cancer
and reproductive history. For those risk factors for
which little relation was observed among women of
all ages in our sample, future more detailed analyses
may help to clarify these apparent inconsistences with
previous studies. For example, risk of breast cancer
is likely to vary with age or menopausal status (e.g.,
important when examining body mass index). Other
possibilities to consider include variations in the pat-
terns of use (relevant, e.g., when examining use of
alcohol, tobacco, or hormones); or variations in mo-
lecular markers. Alternatively, it may also indicate that
other non-traditional factors, such as environmental
exposures, play a role in breast cancer risk in this Long
Island population.
There was a difference between cases and controls
in the time lag between the reference date and the in-
terview date, with cases interviewed on average within
about 3 months of diagnosis and the controls within
about 5 12 months of identification. This is a common
feature of case-control studies when cases are deliber-
ately recruited more quickly than controls, particularly
when survival rates for the disease under study are low.
We employed this strategy for another reason, namely
to obtain prechemotherapy blood samples. The impact
of this recruitment strategy on recall has not been well
studied. For most factors, cases and controls are asked
to recall lifetime or historical exposures that occurred
prior to the reference date, and in this scenario a differ-
ence of 2–3 months has been presumed to make little
difference when recalling events that occurred long
ago. However, a few-month differential could possibly
affect recall of those exposures that occur at the ref-
erence date. However, our pilot data [39] indicate that
serial blood measures of organochlorines taken several
months apart are very highly correlated among women
without breast cancer.
Blood donation
To address the primary hypotheses of the LIBCSP,
blood sample collection to assess the exposures of in-
terest was a key component of the study. Although
response rates were lower among controls than anti-
cipated (to the telephone screener among those under
65 and to the interview among those 65 years and
older), among respondents who completed the in-
terview there was no case-control differential with
nearly three-quarters of case and control participants
donating a blood sample. Although there are some
differences between blood donors and non-donors, the
proportion of eligible subjects who donated blood is
comparable to other population-based studies with a
phlebotomy component [50]. Thus, LIBCSP study
results are likely to be as representative of the general
population as those from other major population-based
studies of breast cancer.
Environmental samples
Long-term residents differed from other LIBCSP re-
spondents on a number of breast cancer risk factors
as would be expected, given that length of residence
is often associated with age and other demographic
and socioeconomic characteristics. However, the ran-
dom sample with a complete set of dust, water, and
soil samples available did not differ from other long-
term residents. Thus, the results based on these mea-
surements should be applicable to all adult female
long-term residents on Long Island.
Future directions
A number of members from the Long Island lay com-
munity are concerned about the potential role in breast
cancer development of chemicals other than those un-
der study in the LIBCSP. Thus, the bank of stored sera
and urine may prove to be a valuable resource in the
future for other biomarker studies with environmental
exposure hypotheses.
Several LIBCSP investigators have collaborated on
a component study that demonstrates the feasibility
of using geographic modeling to estimate a subject’s
past exposures (e.g., to PAH) based on a mathematical
model that incorporates ecologic measures, dispersal
mechanisms, and the subject’s self-reported history
of residential addresses [51]. These techniques could
be useful for estimating past exposures to agents for
which feasible biomarkers of long-term exposures
have yet to be developed.
Current research activities of many of the LIBCSP
collaborators are focused on the molecular epidemi-
ology of breast cancer and potential gene-environment
interactions. These include examination of oncogenes,
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estrogen and carcinogen metabolizing enzymes, poly-
morphisms associated with oxidative stress and DNA
repair, and other molecular markers, and how they
may affect breast cancer risk, or whether they modify
the risk associated with environmental exposures and
breast cancer among women on Long Island. Exam-
ination of these markers in an epidemiologic context
could help to clarify the association between an envir-
onmental agent and breast cancer risk by identifying
subgroups of susceptible individuals who may be at a
particularly high risk of breast cancer. Such a strategy
has begun to help illuminate the relation between ci-
garette smoking (a major source of PAH exposure) and
breast cancer, for example, by identifying subgroups
who are slow metabolizers of tobacco carcinogens
[33]. The already established LIBCSP blood bank is
being drawn upon to conduct some of these assays.
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